Rebar Interactive founder Rahlyn Gossen was quoted in an Outsourcing Pharma article titled “How Prevalent is Dual Enrollment in Clinical Trials? Opinion Split.” The article discusses the prevalence of dual enrollment, as well as the clinical trial complications that can arise from it.
Clinical Trial Bytes
Our clinical trial newsletter includes exclusive digital strategy, patient experience, and innovation information not available on our website. Sign up now!
About Rahlyn Gossen
Founder of Rebar Interactive, a digital strategy and marketing company serving the clinical research industry. Former clinical research coordinator. Patient experience enthusiast, health tech geek, and proud New Orleanian.
Leave a Reply